Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

Canadian Advanced Parkinson DUODOPA-Treated Patients Observational Study Evaluating Long-Term Health Outcomes in Centers of Excellence (CADENCE)

This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with Duodopa (levodopa/carbidopa intestinal gel).

Inclusion Criteria:

• Diagnosed with advanced Parkinson's Disease
• Prescribed Duodopa by his/her treating physician.

Exclusion Criteria:

• Patients who were previously treated with Duodopa.
• Presence of other condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of advanced PD.